Serveur d'exploration sur l'opéra

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.

Identifieur interne : 000308 ( PubMed/Corpus ); précédent : 000307; suivant : 000309

Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.

Auteurs : Bin Shi ; Ed Keough ; Andrea Matter ; Karen Leander ; Stephanie Young ; Ed Carlini ; Alan B. Sachs ; Weikang Tao ; Marc Abrams ; Bonnie Howell ; Laura Sepp-Lorenzino

Source :

RBID : pubmed:21804077

English descriptors

Abstract

Chemically stabilized small interfering RNA (siRNA) can be delivered systemically by intravenous injection of lipid nanoparticles (LNPs) in rodents and primates. The biodistribution and kinetics of LNP-siRNA delivery in mice at organ and cellular resolution have been studied using immunofluorescence (IF) staining and quantitative polymerase chain reaction (qPCR). At 0.5 and 2 hr post tail vein injection of Cy5-labeled siRNA encapsulated in LNP, the organ rank-order of siRNA levels is liver > spleen > kidney, with only negligible accumulation in duodenum, lung, heart, and brain. Similar conclusions were drawn by using qPCR to measure tissue siRNA levels as a secondary end point. siRNA levels in these tissues decreased by more than 10-fold after 24 hr. Within the liver, LNPs delivered siRNA to hepatocytes, Kupffer cells, and sinusoids in a time-dependent manner, as revealed by IF staining and signal quantitation methods established using OPERA/Columbus software. siRNA first accumulated in liver sinusoids and trafficked to hepatocytes by 2 hr post dose, corresponding to the onset of target mRNA silencing. Fluorescence in situ hybridization methods were used to detect both strands of siRNA in fixed tissues. Collectively, the authors have implemented a platform to evaluate biodistribution of siRNA across cell types and across tissues in vivo, with the objective of elucidating the pharmacokinetic and pharmacodynamic relationship to guide optimization of delivery vehicles.

DOI: 10.1369/0022155411410885
PubMed: 21804077

Links to Exploration step

pubmed:21804077

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.</title>
<author>
<name sortKey="Shi, Bin" sort="Shi, Bin" uniqKey="Shi B" first="Bin" last="Shi">Bin Shi</name>
<affiliation>
<nlm:affiliation>Department of RNA Therapeutics, Merck Research Laboratories, Merck & Co, West Point, Pennsylvania 19486, USA. bin_shi@merck.com</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Keough, Ed" sort="Keough, Ed" uniqKey="Keough E" first="Ed" last="Keough">Ed Keough</name>
</author>
<author>
<name sortKey="Matter, Andrea" sort="Matter, Andrea" uniqKey="Matter A" first="Andrea" last="Matter">Andrea Matter</name>
</author>
<author>
<name sortKey="Leander, Karen" sort="Leander, Karen" uniqKey="Leander K" first="Karen" last="Leander">Karen Leander</name>
</author>
<author>
<name sortKey="Young, Stephanie" sort="Young, Stephanie" uniqKey="Young S" first="Stephanie" last="Young">Stephanie Young</name>
</author>
<author>
<name sortKey="Carlini, Ed" sort="Carlini, Ed" uniqKey="Carlini E" first="Ed" last="Carlini">Ed Carlini</name>
</author>
<author>
<name sortKey="Sachs, Alan B" sort="Sachs, Alan B" uniqKey="Sachs A" first="Alan B" last="Sachs">Alan B. Sachs</name>
</author>
<author>
<name sortKey="Tao, Weikang" sort="Tao, Weikang" uniqKey="Tao W" first="Weikang" last="Tao">Weikang Tao</name>
</author>
<author>
<name sortKey="Abrams, Marc" sort="Abrams, Marc" uniqKey="Abrams M" first="Marc" last="Abrams">Marc Abrams</name>
</author>
<author>
<name sortKey="Howell, Bonnie" sort="Howell, Bonnie" uniqKey="Howell B" first="Bonnie" last="Howell">Bonnie Howell</name>
</author>
<author>
<name sortKey="Sepp Lorenzino, Laura" sort="Sepp Lorenzino, Laura" uniqKey="Sepp Lorenzino L" first="Laura" last="Sepp-Lorenzino">Laura Sepp-Lorenzino</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="doi">10.1369/0022155411410885</idno>
<idno type="RBID">pubmed:21804077</idno>
<idno type="pmid">21804077</idno>
<idno type="wicri:Area/PubMed/Corpus">000308</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.</title>
<author>
<name sortKey="Shi, Bin" sort="Shi, Bin" uniqKey="Shi B" first="Bin" last="Shi">Bin Shi</name>
<affiliation>
<nlm:affiliation>Department of RNA Therapeutics, Merck Research Laboratories, Merck & Co, West Point, Pennsylvania 19486, USA. bin_shi@merck.com</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Keough, Ed" sort="Keough, Ed" uniqKey="Keough E" first="Ed" last="Keough">Ed Keough</name>
</author>
<author>
<name sortKey="Matter, Andrea" sort="Matter, Andrea" uniqKey="Matter A" first="Andrea" last="Matter">Andrea Matter</name>
</author>
<author>
<name sortKey="Leander, Karen" sort="Leander, Karen" uniqKey="Leander K" first="Karen" last="Leander">Karen Leander</name>
</author>
<author>
<name sortKey="Young, Stephanie" sort="Young, Stephanie" uniqKey="Young S" first="Stephanie" last="Young">Stephanie Young</name>
</author>
<author>
<name sortKey="Carlini, Ed" sort="Carlini, Ed" uniqKey="Carlini E" first="Ed" last="Carlini">Ed Carlini</name>
</author>
<author>
<name sortKey="Sachs, Alan B" sort="Sachs, Alan B" uniqKey="Sachs A" first="Alan B" last="Sachs">Alan B. Sachs</name>
</author>
<author>
<name sortKey="Tao, Weikang" sort="Tao, Weikang" uniqKey="Tao W" first="Weikang" last="Tao">Weikang Tao</name>
</author>
<author>
<name sortKey="Abrams, Marc" sort="Abrams, Marc" uniqKey="Abrams M" first="Marc" last="Abrams">Marc Abrams</name>
</author>
<author>
<name sortKey="Howell, Bonnie" sort="Howell, Bonnie" uniqKey="Howell B" first="Bonnie" last="Howell">Bonnie Howell</name>
</author>
<author>
<name sortKey="Sepp Lorenzino, Laura" sort="Sepp Lorenzino, Laura" uniqKey="Sepp Lorenzino L" first="Laura" last="Sepp-Lorenzino">Laura Sepp-Lorenzino</name>
</author>
</analytic>
<series>
<title level="j">The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society</title>
<idno type="e-ISSN">1551-5044</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Autoantigens (genetics)</term>
<term>Autoantigens (metabolism)</term>
<term>Drug Carriers</term>
<term>Fluorescent Antibody Technique</term>
<term>Gene Knockdown Techniques</term>
<term>In Situ Hybridization, Fluorescence</term>
<term>Lipids</term>
<term>Mice</term>
<term>Nanoparticles</term>
<term>RNA, Messenger (genetics)</term>
<term>RNA, Messenger (metabolism)</term>
<term>RNA, Small Interfering (administration & dosage)</term>
<term>RNA, Small Interfering (metabolism)</term>
<term>Ribonucleoproteins (genetics)</term>
<term>Ribonucleoproteins (metabolism)</term>
<term>Tissue Distribution</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>RNA, Small Interfering</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Autoantigens</term>
<term>RNA, Messenger</term>
<term>Ribonucleoproteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Autoantigens</term>
<term>RNA, Messenger</term>
<term>RNA, Small Interfering</term>
<term>Ribonucleoproteins</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Drug Carriers</term>
<term>Fluorescent Antibody Technique</term>
<term>Gene Knockdown Techniques</term>
<term>In Situ Hybridization, Fluorescence</term>
<term>Lipids</term>
<term>Mice</term>
<term>Nanoparticles</term>
<term>Tissue Distribution</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Chemically stabilized small interfering RNA (siRNA) can be delivered systemically by intravenous injection of lipid nanoparticles (LNPs) in rodents and primates. The biodistribution and kinetics of LNP-siRNA delivery in mice at organ and cellular resolution have been studied using immunofluorescence (IF) staining and quantitative polymerase chain reaction (qPCR). At 0.5 and 2 hr post tail vein injection of Cy5-labeled siRNA encapsulated in LNP, the organ rank-order of siRNA levels is liver > spleen > kidney, with only negligible accumulation in duodenum, lung, heart, and brain. Similar conclusions were drawn by using qPCR to measure tissue siRNA levels as a secondary end point. siRNA levels in these tissues decreased by more than 10-fold after 24 hr. Within the liver, LNPs delivered siRNA to hepatocytes, Kupffer cells, and sinusoids in a time-dependent manner, as revealed by IF staining and signal quantitation methods established using OPERA/Columbus software. siRNA first accumulated in liver sinusoids and trafficked to hepatocytes by 2 hr post dose, corresponding to the onset of target mRNA silencing. Fluorescence in situ hybridization methods were used to detect both strands of siRNA in fixed tissues. Collectively, the authors have implemented a platform to evaluate biodistribution of siRNA across cell types and across tissues in vivo, with the objective of elucidating the pharmacokinetic and pharmacodynamic relationship to guide optimization of delivery vehicles.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">21804077</PMID>
<DateCreated>
<Year>2011</Year>
<Month>08</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2011</Year>
<Month>09</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>02</Month>
<Day>04</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1551-5044</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>59</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2011</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society</Title>
<ISOAbbreviation>J. Histochem. Cytochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.</ArticleTitle>
<Pagination>
<MedlinePgn>727-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1369/0022155411410885</ELocationID>
<Abstract>
<AbstractText>Chemically stabilized small interfering RNA (siRNA) can be delivered systemically by intravenous injection of lipid nanoparticles (LNPs) in rodents and primates. The biodistribution and kinetics of LNP-siRNA delivery in mice at organ and cellular resolution have been studied using immunofluorescence (IF) staining and quantitative polymerase chain reaction (qPCR). At 0.5 and 2 hr post tail vein injection of Cy5-labeled siRNA encapsulated in LNP, the organ rank-order of siRNA levels is liver > spleen > kidney, with only negligible accumulation in duodenum, lung, heart, and brain. Similar conclusions were drawn by using qPCR to measure tissue siRNA levels as a secondary end point. siRNA levels in these tissues decreased by more than 10-fold after 24 hr. Within the liver, LNPs delivered siRNA to hepatocytes, Kupffer cells, and sinusoids in a time-dependent manner, as revealed by IF staining and signal quantitation methods established using OPERA/Columbus software. siRNA first accumulated in liver sinusoids and trafficked to hepatocytes by 2 hr post dose, corresponding to the onset of target mRNA silencing. Fluorescence in situ hybridization methods were used to detect both strands of siRNA in fixed tissues. Collectively, the authors have implemented a platform to evaluate biodistribution of siRNA across cell types and across tissues in vivo, with the objective of elucidating the pharmacokinetic and pharmacodynamic relationship to guide optimization of delivery vehicles.</AbstractText>
<CopyrightInformation>© The Author(s) 2011</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shi</LastName>
<ForeName>Bin</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of RNA Therapeutics, Merck Research Laboratories, Merck & Co, West Point, Pennsylvania 19486, USA. bin_shi@merck.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Keough</LastName>
<ForeName>Ed</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Matter</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Leander</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Young</LastName>
<ForeName>Stephanie</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Carlini</LastName>
<ForeName>Ed</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sachs</LastName>
<ForeName>Alan B</ForeName>
<Initials>AB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tao</LastName>
<ForeName>Weikang</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Abrams</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Howell</LastName>
<ForeName>Bonnie</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sepp-Lorenzino</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Histochem Cytochem</MedlineTA>
<NlmUniqueID>9815334</NlmUniqueID>
<ISSNLinking>0022-1554</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004337">Drug Carriers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008055">Lipids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012261">Ribonucleoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C035416">SS-B antigen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Nucleic Acids Res. 1989 Mar 25;17(6):2233-44</RefSource>
<PMID Version="1">2468131</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Autoimmun. 1989 Aug;2(4):321-7</RefSource>
<PMID Version="1">2476998</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 1993 Mar 15;81(6):1607-13</RefSource>
<PMID Version="1">7680921</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1993 Dec 3;75(5):843-54</RefSource>
<PMID Version="1">8252621</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 1994 Feb;19(2):480-8</RefSource>
<PMID Version="1">8294104</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 1994 Aug;20(2):425-35</RefSource>
<PMID Version="1">7519163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9580-4</RefSource>
<PMID Version="1">7568176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol. 1995 Oct;269(4 Pt 1):C1057-62</RefSource>
<PMID Version="1">7485446</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Carcinogenesis. 1995 Dec;16(12):3083-5</RefSource>
<PMID Version="1">8603489</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Biotechnol. 2009 Sep;27(9):839-49</RefSource>
<PMID Version="1">19701187</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oligonucleotides. 2009 Sep;19(3):209-22</RefSource>
<PMID Version="1">19653880</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharm. 2009 Sep-Oct;6(5):1409-16</RefSource>
<PMID Version="1">19298054</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pathol. 2009 Nov;219(3):365-72</RefSource>
<PMID Version="1">19718708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Gene Ther. 2008 Nov;19(11):1325-31</RefSource>
<PMID Version="1">19848584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Top Med Chem. 2009;9(12):1088-97</RefSource>
<PMID Version="1">19860709</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Top Med Chem. 2009;9(12):1117-29</RefSource>
<PMID Version="1">19860712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biomed Microdevices. 2009 Dec;11(6):1187-94</RefSource>
<PMID Version="1">19609680</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Mater. 2009 Dec;8(12):935-9</RefSource>
<PMID Version="1">19881498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Ther. 2010 Jan;18(1):171-80</RefSource>
<PMID Version="1">19738601</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2010 Apr 15;464(7291):1067-70</RefSource>
<PMID Version="1">20305636</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Ther. 2010 Sep;18(9):1657-66</RefSource>
<PMID Version="1">20628357</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2010 Nov;53(5):903-10</RefSource>
<PMID Version="1">20739085</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS J. 2010 Dec;277(23):4814-27</RefSource>
<PMID Version="1">21078116</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pharmacol Toxicol Methods. 2011 Mar-Apr;63(2):168-73</RefSource>
<PMID Version="1">20884364</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1998 Feb 19;391(6669):806-11</RefSource>
<PMID Version="1">9486653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2004 Nov 11;432(7014):173-8</RefSource>
<PMID Version="1">15538359</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biomed Mater Res A. 2005 Apr 1;73(1):80-5</RefSource>
<PMID Version="1">15714502</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Toxicol Pathol. 2005;33(1):27-34</RefSource>
<PMID Version="1">15805053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2005 Jun;41(6):1349-56</RefSource>
<PMID Version="1">15880588</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pathol Res Pract. 2005;201(5):379-84</RefSource>
<PMID Version="1">16047947</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Biotechnol. 2005 Aug;23(8):1002-7</RefSource>
<PMID Version="1">16041363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2005 Nov 18;123(4):607-20</RefSource>
<PMID Version="1">16271386</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Pharm. 2006 Jan 3;307(1):93-102</RefSource>
<PMID Version="1">16303268</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2006 Mar 10;124(5):915-27</RefSource>
<PMID Version="1">16530040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Hematol. 2006 Mar;34(3):348-58</RefSource>
<PMID Version="1">16543069</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Rep. 2006 Mar;7(3):314-20</RefSource>
<PMID Version="1">16439995</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Biotechnol. 2006 Aug;24(8):1005-15</RefSource>
<PMID Version="1">16823371</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Histochem Cell Biol. 2006 Aug;126(2):283-91</RefSource>
<PMID Version="1">16508759</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Cell Res. 2007 Jan 1;313(1):179-94</RefSource>
<PMID Version="1">17112511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gene Ther. 2007 Apr;14(7):604-12</RefSource>
<PMID Version="1">17235290</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):12982-7</RefSource>
<PMID Version="1">17652171</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Pharm. 2007 Sep 5;342(1-2):215-21</RefSource>
<PMID Version="1">17566676</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15549-54</RefSource>
<PMID Version="1">17875985</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Protoc. 2007;2(10):2520-8</RefSource>
<PMID Version="1">17947994</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol Methods. 2008 Jan;147(1):54-60</RefSource>
<PMID Version="1">17850893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol Methods. 2008 Mar;148(1-2):277-82</RefSource>
<PMID Version="1">18207578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biochem. 2008 Apr;143(4):537-45</RefSource>
<PMID Version="1">18182385</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Pharmacol Ther. 2008 Nov;84(5):628-32</RefSource>
<PMID Version="1">18800034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16320-5</RefSource>
<PMID Version="1">18922784</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Exp Pharmacol Physiol. 2008 Nov;35(11):1371-6</RefSource>
<PMID Version="1">18565190</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Expert Opin Drug Deliv. 2008 Dec;5(12):1301-11</RefSource>
<PMID Version="1">19040393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Yakugaku Zasshi. 2008 Dec;128(12):1743-9</RefSource>
<PMID Version="1">19043293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioconjug Chem. 2009 Jan;20(1):174-82</RefSource>
<PMID Version="1">19093855</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Methods. 2009 Feb;6(2):139-41</RefSource>
<PMID Version="1">19137005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biomacromolecules. 2009 Feb 9;10(2):408-16</RefSource>
<PMID Version="1">19133718</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Control Release. 2009 Mar 4;134(2):132-40</RefSource>
<PMID Version="1">19084037</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Cycle. 2009 Mar 15;8(6):853-9</RefSource>
<PMID Version="1">19221492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Expert Opin Biol Ther. 2009 May;9(5):609-19</RefSource>
<PMID Version="1">19392577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2009 Apr 30;458(7242):1180-4</RefSource>
<PMID Version="1">19407801</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oligonucleotides. 2009 Jun;19(2):203-8</RefSource>
<PMID Version="1">19284311</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Histochem Cell Biol. 2009 Jun;131(6):713-26</RefSource>
<PMID Version="1">19255771</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Drug Deliv Rev. 2009 Jul 25;61(9):721-31</RefSource>
<PMID Version="1">19328215</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Drug Deliv Rev. 2009 Jul 25;61(9):732-45</RefSource>
<PMID Version="1">19341774</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharm. 2009 May-Jun;6(3):763-71</RefSource>
<PMID Version="1">19292453</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Ther. 2009 Jul;17(7):1225-33</RefSource>
<PMID Version="1">19401674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Control Release. 2009 Sep 1;138(2):148-59</RefSource>
<PMID Version="1">19463870</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2009 Sep 1;183(5):3309-16</RefSource>
<PMID Version="1">19641138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pflugers Arch. 2001 Nov;443(2):188-95</RefSource>
<PMID Version="1">11713643</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2002 May;35(5):1093-103</RefSource>
<PMID Version="1">11981759</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Surg Pathol. 2002 Aug;26(8):978-88</RefSource>
<PMID Version="1">12170084</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Ther. 2003 Jan;7(1):35-43</RefSource>
<PMID Version="1">12573616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Crit Rev Ther Drug Carrier Syst. 2002;19(4-5):277-306</RefSource>
<PMID Version="1">12661696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2003 Dec 1;171(11):6046-51</RefSource>
<PMID Version="1">14634117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1985 Apr;82(7):2115-9</RefSource>
<PMID Version="1">3856888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1987 Sep 25;262(27):13020-6</RefSource>
<PMID Version="1">2820961</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 1987 Oct;105(4):1473-8</RefSource>
<PMID Version="1">3312229</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001324">Autoantigens</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004337">Drug Carriers</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005455">Fluorescent Antibody Technique</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055785">Gene Knockdown Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017404">In Situ Hybridization, Fluorescence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008055">Lipids</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D053758">Nanoparticles</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012333">RNA, Messenger</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D034741">RNA, Small Interfering</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012261">Ribonucleoproteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014018">Tissue Distribution</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC3261601</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>8</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>8</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>9</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pii">59/8/727</ArticleId>
<ArticleId IdType="doi">10.1369/0022155411410885</ArticleId>
<ArticleId IdType="pubmed">21804077</ArticleId>
<ArticleId IdType="pmc">PMC3261601</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000308 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000308 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    OperaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:21804077
   |texte=   Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:21804077" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a OperaV1 

Wicri

This area was generated with Dilib version V0.6.21.
Data generation: Thu Apr 14 14:59:05 2016. Site generation: Thu Oct 8 06:48:41 2020